Direktorat Registrasi ObatValid

RYBREVANT

Claim this product
BPOM Number
DKI2660002249A1
Approved
13 April 2026
Expiry
31 March 2031
Form
LARUTAN KONSENTRAT UNTUK INFUS

About This Registration

RYBREVANT is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2660002249A1. Its current registration status is Valid, with the licence valid until 31 March 2031. The product is registered to SOHO INDUSTRI PHARMASI - INDONESIA. BPOM first approved this registration in March 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 1 VIAL @ 350 MG/7 ML
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

AMIVANTAMAB

Market Intelligence

Owner Portfolio
SOHO INDUSTRI PHARMASI - INDONESIA holds 125 BPOM registrations
Manufacturer Scale
SOHO INDUSTRI PHARMASI - INDONESIA produces 125 registered products
Registration Age
Registered for 5 months

FDA Cross-Reference

via openFDA
Generic Name
AMIVANTAMAB-VMJW
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAVENOUS

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from SOHO INDUSTRI PHARMASI - INDONESIA

DARZALEX FASPRO

-DKI2660002343A1
Valid
Approved: Jul 19, 2026LARUTAN INJEKSI
View product →

CAELYX

-DKI2405000849A1
Valid
Approved: Jul 1, 2026INFUS
View product →

OPSUMIT

-DKI2652500317A1
Valid
Approved: Jun 5, 2026TABLET SALUT SELAPUT
View product →

RYBREVANT

-DKI2660002249A1
Valid
Approved: Mar 31, 2026LARUTAN KONSENTRAT UNTUK INFUS
View product →

PRAMIFROL ER

-DKL2524231314A1
Valid
Approved: Sep 26, 2025TABLET PELEPASAN LAMBAT
View product →

Products in the same class

DEXAMETHASONE

-GKL1944400910A1
Valid
Approved: Aug 10, 2026TABLET
KIMIA FARMA TBK. - INDONESIA
View product →

LANTUS

-DKI0259201443A5
Valid
Approved: May 27, 2026LARUTAN INJEKSI
KALVENTIS SINERGI FARMA - INDONESIA
View product →

GABAPENTIN

-GKL2112431301B1
Valid
Approved: May 11, 2026KAPSUL
KIMIA FARMA TBK. - INDONESIA
View product →

PARAMEX NYERI OTOT

-DTL9613013110A1
Valid
Approved: Apr 12, 2026TABLET
KONIMEX - INDONESIA
View product →

DEXTEEM PLUS

-DKL9306409410A1
Valid
Approved: Mar 29, 2026TABLET
ERLIMPEX - INDONESIA
View product →
1